Pasithea Therapeutics annual total assets
2021
2022
2023
2024
2025
Pasithea Therapeutics Total Assets Growth & History (KTTA)
Pasithea Therapeutics's total assets was $60.2M for fiscal 2025.
View full Pasithea Therapeutics company overviewPasithea Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $60.2M | $44.2M | +274.98% |
| 2024 | 2024-12-31 | $16.1M | −$10.1M | −38.49% |
| 2023 | 2023-12-31 | $26.1M | −$19.1M | −42.19% |
| 2022 | 2022-12-31 | $45.2M | −$8.1M | −15.27% |
| 2021 | 2021-12-31 | $53.3M | — | — |
Pasithea Therapeutics quarterly total assets
As of Dec 31, 2020
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $51.7M | $34.7M | +204.01% |
| Q1 2026 | 2026-03-31 | $56.4M | $41.7M | +284.44% |
| Q4 2025 | 2025-12-31 | $60.2M | $44.2M | +274.98% |
| Q3 2025 | 2025-09-30 | $13.6M | −$5.0M | −26.86% |
| Q2 2025 | 2025-06-30 | $17.0M | −$654,242 | −3.70% |
| Q1 2025 | 2025-03-31 | $14.7M | −$7.7M | −34.58% |
| Q4 2024 | 2024-12-31 | $16.1M | −$10.1M | −38.49% |
| Q3 2024 | 2024-09-30 | $18.6M | −$12.0M | −39.21% |
| Q2 2024 | 2024-06-30 | $17.7M | −$20.5M | −53.70% |
| Q1 2024 | 2024-03-31 | $22.4M | −$19.6M | −46.70% |
| Q4 2023 | 2023-12-31 | $26.1M | −$19.1M | −42.19% |
| Q3 2023 | 2023-09-30 | $30.7M | −$19.0M | −38.20% |
| Q2 2023 | 2023-06-30 | $38.1M | −$14.9M | −28.06% |
| Q1 2023 | 2023-03-31 | $42.0M | −$9.0M | −17.69% |
| Q4 2022 | 2022-12-31 | $45.2M | −$8.1M | −15.27% |
| Q3 2022 | 2022-09-30 | $49.6M | $28.6M | +135.75% |
| Q2 2022 | 2022-06-30 | $53.0M | — | — |
| Q1 2022 | 2022-03-31 | $51.1M | — | — |
| Q4 2021 | 2021-12-31 | $53.3M | $53.1M | +21403.88% |
| Q3 2021 | 2021-09-30 | $21.0M | — | — |
| As of Dec 31, 2020 | 2020-12-31 | $247,958 | — | — |
Pasithea Therapeutics total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Pasithea Therapeutics's total assets increased from $53.3M to $60.2M, a change of $6.9M. The latest reported quarter, Q2 2026, shows $51.7M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pasithea Therapeutics source filings ↗